QED Biomedical Ltd. provide Systematic & Rapid Reviews of data from early stage pre-clinical and biomedical studies

We are pioneering evidence based methods to combat low attrition rates, the reproducibility crisis, stealth research and publication bias

We can help you identify the risks in early biotechnology innovations; providing optimal decision making

We can assist with due diligence. Identifying the reproducibility and validity of new biomedical technologies


Contact us to find out how we can support your decision-making on new technologies






Areas of expertise

translational medicine, precision medicine, genomics, stem cell therapy, immunotherapy and gene therapy

We have particular expertise in preclinical models (human cell culture, organoids, 3D spheroids and patient derived xenografts), helping clients understand which are the best validated models for their needs



Carousel imageCarousel imageCarousel imageCarousel imageCarousel imageCarousel imageCarousel imageCarousel imageCarousel imageCarousel image